EP
DSGN icon

Essential Partners’s Design Therapeutics DSGN Stock Holding History

Essential Partners’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13 Hold
1
– – ﹤0.01% 2829
2026
Q2 		$14 Hold
1
– – ﹤0.01% 2840
2026
Q1 		$11 Buy
+1
New +$10 ﹤0.01% 2836

Other funds holding DSGN

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Essential Partners's DSGN Position: Q3 2026 in Review

Essential Partners held its Design Therapeutics (DSGN) position steady in Q3 2026 at 1 share worth $13. The position accounts for ﹤0.01% of the portfolio, ranked #2829.

Essential Partners first reported a position in DSGN in Q1 2026 and has held it in 3 quarters since. The position peaked at $14 in Q2 2026. 5 funds tracked by Wall St. Rank hold DSGN as of Q3 2026.

  • Essential Partners held 1 share of Design Therapeutics worth $13 as of Q3 2026.
  • Essential Partners left its Design Therapeutics share count unchanged in Q3 2026.
  • Design Therapeutics made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2829 holding.
  • Essential Partners first reported a position in Design Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Essential Partners's Design Therapeutics position peaked at $14 in Q2 2026.
  • 5 funds tracked by Wall St. Rank held Design Therapeutics as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.